HCPLive Network
Latest Rheumatology Headlines
Thursday, November 20, 2014
By Richard Robinson
Intra-articular injection of two widely used plant and mineral extract-based formulations provide long-lasting pain relief in patients with moderate to severe pain from knee osteoarthritis, according to the first-ever double-blind trial of the treatments.
Thursday, November 20, 2014
By Richard Robinson
A “biosimilar” form of etanercept is clinically equivalent to the branded form for rheumatoid arthritis, according to data presented at the 2014 annual meeting of the American College of Rheumatology.
Thursday, November 20, 2014
By Richard Robinson
A blood test may offer a reliable way to identify rheumatoid arthritis patients who are unlikely to respond to anti-tumor necrosis factor-alpha inhibitors, speeding treatment with other drugs and lowering costs.
Thursday, November 20, 2014
By Adam Hochron
As hospitals around the country deal with the newly instituted readmission penalties many are having to look at how they will handle providing the same level of care without some of the money they counted on in the past.
Thursday, November 20, 2014
For adults with chronic noncancer pain, mortality is increased for long-term opioid users, with a smaller increase seen for short-term opioid users and for nonusers versus those without chronic pain, according to a study published in the November issue of PAIN.
Wednesday, November 19, 2014
By Rachel Lutz
Women using intrauterine devices with a family history of rheumatoid arthritis are at greater risk for the condition.
Wednesday, November 19, 2014
By Richard Robinson
Running does not increase the risk for knee osteoarthritis (OA), according to study results presented at the 2014 annual meeting of the American College of Rheumatology. No increase in knee OA or knee pain was associated with habitual running in any age group in a study of over 600 individuals who reported running as a regular activity at some point in their lives.
Wednesday, November 19, 2014
By Richard Robinson
Administration of the varicella zoster vaccine is safe in patients with rheumatoid arthritis or other rheumatic conditions who are taking biologic disease-modifying anti-rheumatic drugs, according to study results presented at the 2014 American College of Rheumatology annual meeting.
Wednesday, November 19, 2014
By Richard Robinson
Adjusting treatment to maintain tight control of disease-related disability reduces mortality in rheumatoid arthritis, according to new research presented at the 2014 American College of Rheumatology annual meeting.
Tuesday, November 18, 2014
By Richard Robinson
A Phase 3 trial of the monoclonal antibody secukinumab indicates it is an effective treatment for patients with ankylosing spondylitis (AS) incompletely treated by standard therapy, according to data presented at the 2014 American College of Rheumatology meeting.
Email Signup
Physician's Money Digest
Job growth, increasing consumer confidence, and lower gas prices will fuel moderate spending growth this holiday season, according to a new study.
Recently, the International Energy Agency (IEA) published a report on total global investments in one specific form of "energy" in 2012. It pegged investment in this form of energy at between $310 billion and $360 billion. What is it? The answer might surprise you.